 |
BZ73978 |
racemic-tert-butyl acetylphenylalaninate |
68277-06-5 |
|
|
VIEW DETAILS > |
 |
BZ74009 |
rel-2,6-Bis[(4R)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]pyridine |
929270-12-2 |
|
|
VIEW DETAILS > |
 |
BZ99535 |
Rac1-IN-4 |
2924486-45-1 |
C23H16ClN5O2 |
429.8584 |
VIEW DETAILS > |
 |
CA01864 |
rel-(2R,6S)-2-Ethyl-6-methylmorpholine |
3037695-93-2 |
C7H15NO |
129.2001 |
VIEW DETAILS > |
 |
BO84990 |
RANK-RANKL inhibitor S3-15 |
2412947-15-8 |
|
|
VIEW DETAILS > |
 |
CA03022 |
rel-1,1-Dimethylethyl N-[(1R,2S)-2-(aminocarbonyl)cyclohexyl]carbamate |
2417138-22-6 |
C12H22N2O3 |
242.3147 |
VIEW DETAILS > |
 |
AE78953 |
Rapamycin, 41-O-demethyl- |
142382-16-9 |
C50H77NO13 |
900.1453 |
VIEW DETAILS > |
 |
BO43578 |
RS Domain derived peptide |
182570-72-5 |
C44H85N25O15 |
1204.3042 |
VIEW DETAILS > |
 |
AB34074 |
Resorcinol, bis(xylylazo)- |
28514-75-2 |
C22H22N4O2 |
374.4357 |
VIEW DETAILS > |
 |
BB94530 |
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-, mixt. with (2S,2′S)-2,2′-(1,2-ethanediyldiimino)bis[1-butanol], 5-hydroxy-6-methyl-3,4-pyridinedimethanol, pyrazinecarboxamide and 4-pyridinecarboxylic acid hydrazide |
518973-66-5 |
C72H105N13O19 |
1456.6798 |
VIEW DETAILS > |